<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000662467"><TermName>CVP regimen</TermName><TermPronunciation>(… REH-jih-men)</TermPronunciation><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination used to treat slow-growing forms of non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL). It includes the drugs cyclophosphamide, vincristine sulfate, and prednisone. Also called CVP.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000725927" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;CVP regimen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000725926" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen CVP&quot;" language="es" id="_4"/><SpanishTermName>régimen CVP</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura del nombre de un régimen de quimioterapia combinada que se usa para tratar las formas de crecimiento lento del linfoma no Hodgkin (LNH) y la leucemia linfocítica crónica. Incluye los medicamentos ciclofosfamida, sulfato de vincristina y prednisona. También se llama CVP.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-04-23</DateFirstPublished><DateLastModified>2011-01-03</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000688300">CVP</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
